NATIXIS PARTNERS ADVISED THE MENIX GROUP, A PORTFOLIO COMPANY OF FIVE ARROWS, ALONGSIDE TURENNE CAPITAL AND KEENSIGHT, ON THE SALE OF SERF TO STRYKER

Menix Group, a French holding company with leading brands in orthopaedics, dental implantology and cranio-maxillofacial surgery, has sold SERF to Stryker. Founded in 1973, SERF (Société d’Etude, de Recherche et de Fabrication) is a leading orthopedic implants player, specialized in the design, manufacturing and distribution of hip and knee implants. SERF has developed numerous innovative concepts, including the invention of the original Dual Mobility Cup. In 2023, it generated around €60 million of sales. Stryker is a global medical technology company headquartered in the US (c.$18bn in revenue in 2022). The acquisition of SERF will complement Stryker's presence in France and across Europe as well as its global joint replacement portfolio. It will also enable SERF to accelerate its international expansion. Natixis Partners acted as exclusive financial advisor to the Menix Group on the transaction.